Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001209191-23-005423

President and CEO acquired 4,791 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
White Marvin L President and CEO 2023-01-29 Option exercise +4,791 30,555 D
Derivatives
White Marvin L President and CEO 2023-01-29 Option exercise · Restricted Stock Unit −4,791 4,792 D
Loading xslF345X03/doc4.xml…